Isracann Biosciences Indicators Definitive Settlement to Purchase Pure Well being Drugs Developer
Isracann Biosciences Inc. VANCOUVER, British Columbia, March 28, 2022 (GLOBE NEWSWIRE) — Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Firm”) is happy to announce that, additional to the Firm’s information launch dated February 23, 2022, it has entered right into a definitive settlement (the “Settlement”) dated March 24, 2022 with Praesidio Well…